What is Agios Pharmaceuticals, Inc.'s Market Cap?

Agios Pharmaceuticals, Inc.'s Market Cap is $2.1B, based on as-reported figures from SEC (XBRL) filings.

What is Agios Pharmaceuticals, Inc.'s Price / Sales?

Agios Pharmaceuticals, Inc.'s Price / Sales is 21.2×, based on as-reported figures from SEC (XBRL) filings.

What is Agios Pharmaceuticals, Inc.'s Revenue (TTM)?

Agios Pharmaceuticals, Inc.'s Revenue (TTM) is $98.3M, based on as-reported figures from SEC (XBRL) filings.

What is Agios Pharmaceuticals, Inc.'s Net Income (TTM)?

Agios Pharmaceuticals, Inc.'s Net Income (TTM) is -$411.3M, based on as-reported figures from SEC (XBRL) filings.

What is Agios Pharmaceuticals, Inc.'s EBITDA?

Agios Pharmaceuticals, Inc.'s EBITDA is -$453.8M, based on as-reported figures from SEC (XBRL) filings.

What is Agios Pharmaceuticals, Inc.'s Diluted EPS (TTM)?

Agios Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -6.89, based on as-reported figures from SEC (XBRL) filings.

What is Agios Pharmaceuticals, Inc.'s EBITDA Margin?

Agios Pharmaceuticals, Inc.'s EBITDA Margin is -461.5%, based on as-reported figures from SEC (XBRL) filings.

Agios Pharmaceuticals, Inc. (AGIO) Financial Statements

Agios Pharmaceuticals, Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001T8R687

XNAS · usd

35.00▲ 1.45 (4.32%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value—

Trailing P/E—

Price / Sales

EV / Revenue—

EV / EBITDA—

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt—

Trading Information

Previous Close33.55

Day's Range32.23 – 33.93

52-Week Range22.24 – 46.00

Volume815.7K

Avg Volume1.0M

Share Statistics

Shares Outstanding

Employees540

ExchangeXNAS

Listed2013-07-24

Share count as of July 24, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Agios Pharmaceuticals, Inc. (AGIO)

What is Agios Pharmaceuticals, Inc.'s Market Cap?: Agios Pharmaceuticals, Inc.'s Market Cap is $2.1B, based on as-reported figures from SEC (XBRL) filings.
What is Agios Pharmaceuticals, Inc.'s Price / Sales?: Agios Pharmaceuticals, Inc.'s Price / Sales is 21.2×, based on as-reported figures from SEC (XBRL) filings.
What is Agios Pharmaceuticals, Inc.'s Revenue (TTM)?: Agios Pharmaceuticals, Inc.'s Revenue (TTM) is $98.3M, based on as-reported figures from SEC (XBRL) filings.
What is Agios Pharmaceuticals, Inc.'s Net Income (TTM)?: Agios Pharmaceuticals, Inc.'s Net Income (TTM) is -$411.3M, based on as-reported figures from SEC (XBRL) filings.
What is Agios Pharmaceuticals, Inc.'s EBITDA?: Agios Pharmaceuticals, Inc.'s EBITDA is -$453.8M, based on as-reported figures from SEC (XBRL) filings.
What is Agios Pharmaceuticals, Inc.'s Diluted EPS (TTM)?: Agios Pharmaceuticals, Inc.'s Diluted EPS (TTM) is -6.89, based on as-reported figures from SEC (XBRL) filings.
What is Agios Pharmaceuticals, Inc.'s EBITDA Margin?: Agios Pharmaceuticals, Inc.'s EBITDA Margin is -461.5%, based on as-reported figures from SEC (XBRL) filings.